NBIX Earnings Neurocrine Biosciences Inc
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–60 of 60
| Q3 2026 | 2026-09-30 | 1.96 | 2026-11-02 | 10-Q |
| Q2 2026 | 2026-06-30 | 1.39 | 2026-07-31 | 10-Q |
| Q1 2026 | 2026-03-31 | 1.91 | 2026-05-05 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | 1.49 | 2026-02-11 | 10-K |
| FY 2025 | 2025-12-31 | 4.67 | 2026-02-11 | 10-K |
| Q3 2025 | 2025-09-30 | 2.04 | 2025-10-28 | 10-Q |
| Q2 2025 | 2025-06-30 | 1.06 | 2025-07-30 | 10-Q |
| Q1 2025 | 2025-03-31 | 0.08 | 2025-05-05 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | 1.00 | 2025-02-10 | 10-K |
| FY 2024 | 2024-12-31 | 3.29 | 2025-02-10 | 10-K |
| Q3 2024 | 2024-09-30 | 1.24 | 2024-10-30 | 10-Q |
| Q2 2024 | 2024-06-30 | 0.63 | 2024-08-01 | 10-Q |
| Q1 2024 | 2024-03-31 | 0.42 | 2024-05-01 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | 1.49 | 2024-02-09 | 10-K |
| FY 2023 | 2023-12-31 | 2.47 | 2024-02-09 | 10-K |
| Q3 2023 | 2023-09-30 | 0.82 | 2023-10-31 | 10-Q |
| Q2 2023 | 2023-06-30 | 0.95 | 2023-08-01 | 10-Q |
| Q1 2023 | 2023-03-31 | -0.79 | 2023-05-03 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | 0.91 | 2023-02-09 | 10-K |
| FY 2022 | 2022-12-31 | 1.56 | 2023-02-09 | 10-K |
| Q3 2022 | 2022-09-30 | 0.69 | 2022-11-01 | 10-Q |
| Q2 2022 | 2022-06-30 | -0.18 | 2022-08-04 | 10-Q |
| Q1 2022 | 2022-03-31 | 0.14 | 2022-05-04 | 10-Q |
| Q4 2021 (derived) | 2021-12-31 | -0.07 | 2022-02-11 | 10-K |
| FY 2021 | 2021-12-31 | 0.92 | 2022-02-11 | 10-K |
| Q3 2021 | 2021-09-30 | 0.23 | 2021-11-01 | 10-Q |
| Q2 2021 | 2021-06-30 | 0.43 | 2021-08-03 | 10-Q |
| Q1 2021 | 2021-03-31 | 0.33 | 2021-05-05 | 10-Q |
| Q4 2020 | 2020-12-31 | 3.58 | 2021-02-05 | 10-K |
| FY 2020 | 2020-12-31 | 4.16 | 2021-02-05 | 10-K |
| Q3 2020 | 2020-09-30 | -0.62 | 2020-11-09 | 10-Q |
| Q2 2020 | 2020-06-30 | 0.81 | 2020-08-03 | 10-Q |
| Q1 2020 | 2020-03-31 | 0.39 | 2020-05-06 | 10-Q |
| Q4 2019 | 2019-12-31 | 0.35 | 2020-02-07 | 10-K |
| FY 2019 | 2019-12-31 | 0.39 | 2020-02-07 | 10-K |
| Q3 2019 | 2019-09-30 | 0.56 | 2019-11-04 | 10-Q |
| Q2 2019 | 2019-06-30 | 0.54 | 2019-07-29 | 10-Q |
| Q1 2019 | 2019-03-31 | -1.12 | — | — |
| Q4 2018 | 2018-12-31 | 0.19 | 2019-02-08 | 10-K |
| FY 2018 | 2018-12-31 | 0.22 | 2019-02-08 | 10-K |
| Q3 2018 | 2018-09-30 | 0.52 | 2018-11-05 | 10-Q |
| Q2 2018 | 2018-06-30 | -0.07 | — | — |
| Q1 2018 | 2018-03-31 | -0.47 | — | — |
| Q4 2017 | 2017-12-31 | 0.07 | 2018-02-13 | 10-K |
| FY 2017 | 2017-12-31 | -1.62 | 2018-02-13 | 10-K |
| Q3 2017 | 2017-09-30 | -0.13 | — | — |
| Q2 2017 | 2017-06-30 | -0.68 | — | — |
| Q1 2017 | 2017-03-31 | -0.90 | — | — |
| FY 2016 | 2016-12-31 | -1.63 | 2017-02-14 | 10-K |
| FY 2015 | 2015-12-31 | -1.05 | 2016-02-11 | 10-K |
| FY 2014 | 2014-12-31 | -0.81 | 2015-02-09 | 10-K |
| Q4 2013 | 2013-12-31 | -0.16 | 2014-02-11 | 10-K |
| FY 2013 | 2013-12-31 | -0.69 | 2014-02-11 | 10-K |
| Q3 2013 | 2013-09-30 | -0.17 | — | — |
| Q2 2013 | 2013-06-30 | -0.18 | — | — |
| Q1 2013 | 2013-03-31 | -0.18 | — | — |
| Q4 2012 | 2012-12-31 | 0.14 | 2013-02-08 | 10-K |
| FY 2012 | 2012-12-31 | 0.08 | 2013-02-08 | 10-K |
| Q3 2012 | 2012-09-30 | -0.05 | 2012-10-31 | 10-Q |
| Q2 2012 | 2012-06-30 | -0.01 | 2012-07-31 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.